Clozapine, mRNA COVID-19 vaccination and drug-induced myocarditis.

Dawson, Jessica L; Clark, Scott R; Wilton, Lisa R; Chiew, Kim Y; Procter, Nicholas G; Bell, J Simon

Dawson, Jessica L; Clark, Scott R; Wilton, Lisa R; Chiew, Kim Y; Procter, Nicholas G; Bell, J Simon.

Dawson JL; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.
Clark SR; SA Pharmacy, Flinders Medical Centre, Bedford Park, SA, Australia.
Wilton LR; Discipline of Psychiatry, School of Medicine, The University of Adelaide, Adelaide, SA, Australia.
Chiew KY; Office of the Chief Psychiatrist, SA Health, Adelaide, SA, Australia.
Procter NG; Eastern Mental Health Services, Central Adelaide Local Health Network, Adelaide, SA, Australia.
Bell JS; UniSA Clinical & Health Sciences, University of South Australia, Adelaide, SA, Australia.

Aust N Z J Psychiatry ; 56(7): 879, 2022 07.

Article in English | MEDLINE | ID: covidwho-1541997

Subject(s)

Antipsychotic Agents; COVID-19; Clozapine; Myocarditis; Antipsychotic Agents/adverse effects; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Clozapine/adverse effects; Humans; Myocarditis/chemically induced; RNA, Messenger; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antipsychotic Agents / Clozapine / COVID-19 / Myocarditis Topics: Vaccines Limits: Humans Language: English Journal: Aust N Z J Psychiatry Year: 2022 Document Type: Article Affiliation country: 00048674211062135

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google